Table 1 Summary of the primers designed and used in the study.

Human Prox1 (Exon 3–4)

5'-GCT CCA ATA TGC TGA AGA CC-3'

5'-ATC GTT GAT GGC TTG ACG TG-3'

120 bp

2399–2519

Human HNF4α

5'-GGG GTA CCC ATG GCC GAC TAC AGT G-3'

5'-GGG GTA CCG CGC TGA CAC CCA GGC TG-3'

140 bp

122 – 262

Human albumin

5'-CTG TGG GGC ACT TTT GAA AT-3'

5'-AAC ATC CCC TTC ACA GCA TC-3'

154 bp

698 – 851

Human CREB

5'-GAC ACC AGC TGG AGA AGG AC-3'

5'-CTT CTT GGT GTC CCA TGC TT-3'

198 bp

500 – 698

Human AP-4

5'-GTG CCC TCT TTG CAA CAT TT-3'

5'-CTG CCT TGC TGA GCT TCT CT-3'

229 bp

289 – 517

Human N-myc

5'-GAC TGT AGC CAT CCG AGG AC-3'

5'-GTT TTA ATA CCG GGG GTG CT-3'

161 bp

92 – 253

Human MAZ

5'-TAC CAC CTG AAC CGA CAC AA-3'

5'-GCT GCC TCA CAT TTC TCA CA-3'

247 bp

1040 – 1287